What is the Valiant Laboratories Ltd share price today?

The share price of NSE:VALIANTLAB-BE on 01 Oct 2026 (as of 15:05:11 IST) is ₹125.7.

What is the NSE:VALIANTLAB-BE 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:VALIANTLAB-BE 52 week high low range shows a high of ₹132.25 and a low of ₹49.51.

What is the Valiant Laboratories Ltd market cap?

As on 01 Oct 2026, Valiant Laboratories Ltd market cap is ₹6873250000.

What is the shareholding pattern of Valiant Laboratories Ltd Stock?

The shareholding pattern of Valiant Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 74.94% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 25.06% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Valiant Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd is 52.0188, and the Price-to-Book (PB) ratio is 1.424, as on 01 Oct 2026.

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+2.10%

1 Week

-3.67%

1 Month

-6.34%

3 Month

+87.92%

6 Month

+105.17%

YTD

+71.14%

1 Year

+37.81%

5 Year

NA

10 Year

NA

Max

-20.45%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

113.00

111.25

58.08

49.51

High

121.00

126.00

132.25

About

Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

VALIANTLAB-BENSE

LTP

1W Low

1W High

Market cap (₹)

1621.8-182.3 (-10.10%)

1621.80

1936

4,20,483Cr

9329-221 (-2.31%)

8557

9916

2,49,248Cr

4634.9-137.1 (-2.87%)

4198.50

4795

1,77,822Cr

1084-75.5 (-6.51%)

1050

1229.20

1,11,242Cr

2018.9-31.1 (-1.52%)

1833

2150

1,08,062Cr

1305.2-35 (-2.61%)

1170.90

1431.10

1,05,427Cr

2368.2-131.8 (-5.27%)

2297.40

2539.30

99,065Cr

1193.9-14.1 (-1.17%)

1077.30

1316.70

98,492Cr

1652-40.8 (-2.41%)

1592

1777.70

94,477Cr

1957.7-71.6 (-3.53%)

1796.50

2152.10

88,806Cr

117.5-6.87 (-5.52%)

113

128.85

636Cr

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year-27%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-789%

Stock Price CAGR

10 years-

5 years-

3 years-9%

1 year38%

Return on Equity

10 years9%

5 years9%

3 years9%

Last year-1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	-27%
-	-	-	-789%
-	-	-9%	38%
9%	9%	9%	-1%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

MANKIND

DRREDDY

AUROPHARMA

LUPIN

VALIANTLAB-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,621.8	₹420483 Cr	34.76	12.07	62.82	₹11479 Cr
9,329	₹249248 Cr	85.21	34.04	128.41	₹2568 Cr
4,634.9	₹177822 Cr	81.53	16.72	97.06	₹2163 Cr
1,084	₹111242 Cr	24.65	9.42	62.53	₹5040 Cr
2,018.9	₹108062 Cr	98.83	6.8	29.25	₹889 Cr
1,305.2	₹105427 Cr	31.28	9.77	57.87	₹3879 Cr
2,368.2	₹99065 Cr	48.5	13.75	71.08	₹1913 Cr
1,193.9	₹98492 Cr	30.57	5.32	63.99	₹4196 Cr
1,652	₹94477 Cr	25.45	17.95	96.84	₹3505 Cr
1,957.7	₹88806 Cr	16.06	30.95	154.35	₹5333 Cr
117.5	₹636 Cr	39.72	3.89	4.49	-₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
₹115 Cr	₹92 Cr	₹52 Cr	₹46 Cr	₹47 Cr	₹58 Cr	₹35 Cr	₹21 Cr	₹19 Cr	₹31 Cr	₹41 Cr	₹60 Cr	₹51 Cr	₹90 Cr	₹71 Cr	₹88 Cr
₹86 L	₹17 L	₹63 L	₹87 L	₹66 L	-₹2 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹78 L	₹1 Cr
₹116 Cr	₹92 Cr	₹53 Cr	₹47 Cr	₹47 Cr	₹55 Cr	₹37 Cr	₹25 Cr	₹22 Cr	₹33 Cr	₹42 Cr	₹63 Cr	₹54 Cr	₹92 Cr	₹72 Cr	₹89 Cr
₹89 Cr	₹90 Cr	₹55 Cr	₹47 Cr	₹45 Cr	₹54 Cr	₹35 Cr	₹29 Cr	₹22 Cr	₹36 Cr	₹47 Cr	₹61 Cr	₹48 Cr	₹82 Cr	₹61 Cr	₹78 Cr
₹30 Cr	₹5 Cr	-₹26 L	₹95 L	₹3 Cr	₹2 Cr	₹2 Cr	-₹3 Cr	₹43 L	-₹2 Cr	-₹5 Cr	₹2 Cr	₹6 Cr	₹10 Cr	₹11 Cr	₹12 Cr
₹1 Cr	₹1 Cr	₹68 L	₹14 L	₹7 L	₹6 L	₹6 L	₹60,000	₹5 L	₹2 L	₹2 L	₹2 L	₹2 L	₹3 L	₹4 L	₹17 L
₹26 Cr	₹1 Cr	-₹3 Cr	₹28 L	₹2 Cr	₹94 L	₹2 Cr	-₹4 Cr	-₹16 L	-₹3 Cr	-₹5 Cr	₹1 Cr	₹6 Cr	₹10 Cr	₹10 Cr	₹12 Cr
₹21 Cr	₹2 Cr	-₹7 Cr	₹20 L	₹2 Cr	₹70 L	₹2 Cr	-₹5 Cr	-₹51 L	-₹1 Cr	-₹4 Cr	₹79 L	₹4 Cr	₹8 Cr	₹8 Cr	₹9 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023
—	—	—
₹43 Cr	₹43 Cr	₹33 Cr
₹191 Cr	₹193 Cr	₹68 Cr
₹191 Cr	₹193 Cr	₹68 Cr
₹234 Cr	₹237 Cr	₹100 Cr
₹45 Cr	₹15 Cr	₹0
₹59 Cr	₹59 Cr	₹59 Cr
₹1 Cr	₹62 L	₹67 L
₹1 Cr	₹1 Cr	₹2 Cr
₹13 L	₹8 L	₹8 L
₹107 Cr	₹77 Cr	₹62 Cr
—	—	—
₹41 Cr	₹26 Cr	₹47 Cr
₹2 Cr	₹2 Cr	₹3 Cr
₹17 Cr	₹1 Cr	₹0
₹20 L	₹12 L	₹12 L
₹60 Cr	₹29 Cr	₹51 Cr
₹401 Cr	₹343 Cr	₹213 Cr
₹62 Cr	₹3 L	₹3 L
₹121 Cr	₹76 Cr	₹59 Cr
—	—	—
₹71 Cr	₹70 Cr	₹66 Cr
₹22 Cr	₹20 Cr	₹18 Cr
₹48 Cr	₹50 Cr	₹48 Cr
₹156 Cr	₹43 Cr	₹68 L
₹4 Cr	₹24 Cr	₹14 Cr
₹208 Cr	₹117 Cr	₹62 Cr
—	—	—
₹0	₹38 Cr	₹34 Cr
₹4 Cr	₹10 Cr	₹13 Cr
₹72 Cr	₹46 Cr	₹89 Cr
₹76 Cr	₹106 Cr	₹1 Cr
₹81 L	₹2 Cr	₹1 Cr
₹40 Cr	₹24 Cr	₹12 Cr
₹193 Cr	₹226 Cr	₹151 Cr
₹133 Cr	₹196 Cr	₹100 Cr
₹401 Cr	₹343 Cr	₹213 Cr
₹54	₹55	₹31
₹50	₹51	₹31

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023
-₹2 Cr	-₹77 L	₹38 Cr
₹4 Cr	₹2 Cr	₹2 Cr
-₹4 Cr	-₹37 L	₹25 Cr
-₹1 Cr	₹90 L	₹65 Cr
₹1 Cr	₹2 Cr	₹56 Cr
-₹53 Cr	-₹144 Cr	-₹55 Cr
₹45 Cr	₹152 Cr	-₹93 L
-₹7 Cr	₹10 Cr	-₹5 L
₹12 Cr	₹1 Cr	₹1 Cr
₹5 Cr	₹12 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

Shareholding summary

Promoters

74.94%

FII

0%

DII

0%

MF

0%

Others

25.06%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
74.94%	74.94%	74.94%	74.94%	74.94%	74.94%
0.00%	0.20%	0.01%	0.02%	0.63%	0.64%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
25.06%	24.86%	25.05%	25.04%	24.43%	24.42%

Bulk & block deals

Name

Metasoni Alloys Pvt Ltd

Trade Corner

Necta Bloom Vcc - Necta Bloom One

Marwadi Chandarana Intermediaries Brokers Private Limited

Money Logix Securities Pvt Ltd

Jainam Broking Limited

Jaliyan Commodity

Jainam Broking Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
17 Dec 2025	Purchase	2.10 Cr	₹67.33	3.12 L	Bulk	0.574452	NSE
17 Dec 2025	Sell	5.19 L	₹66.98	7.74 K	Bulk	0.014255	NSE
13 Jun 2025	Sell	2.83 Cr	₹120.29	2.35 L	Bulk	0.433049	NSE
31 Jan 2025	Purchase	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
31 Jan 2025	Sell	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
24 Jan 2025	Purchase	5.82 Cr	₹105.78	5.50 L	Bulk	1.012658	NSE
24 Jan 2025	Sell	5.82 Cr	₹105.77	5.50 L	Bulk	1.012658	NSE
07 Jun 2024	Purchase	4.99 Cr	₹142.81	3.49 L	Bulk	0.642841	NSE
07 Jun 2024	Purchase	18.27 L	₹148.54	12.30 K	Bulk	0.022647	NSE
07 Jun 2024	Sell	4.92 Cr	₹142.80	3.44 L	Bulk	0.634071	NSE

Insider trading & SAST

Client name

Valiant Organics Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Jun 2026	Promoter	Acquisition	34.26	—	0	—	1.86 Cr	01 Jan 1900	—	—	SAST	10(5)	—

Valiant Laboratories Share Price

119.80+0.00 (+2.10%)

+37.81% past 1 Year

Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for

Corporate Actions

Date

Type

Details

2025-07-18

Rights

1:4;75.0 (Rights ratio;Offer price)

Company details

Registered office

109, Udyog Kshetra, First Floor Mulund Goregaon Link Road Mulund (West) Mumbai Maharashtra PIN: 400080 Tel No: 022-49712001 / 49717220 / 49717221 Fax No: NULL Email: [email protected] Internet: www.valiantorganics.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Mulesh M Savla, Non Executive Independent Director

Santosh S Vora, Managing Director

Paresh S Shah, Whole Time Director

Shantilal Shivji Vora, Non Executive Director

Sandeep Gupta, Non Executive Director

Sonal A Vira, Non Executive Independent Director

Akshay Gangurde, Company Secretary & Compliance Officer

Ashok Chheda, Non Executive Independent Director

Details

BSE 543998

NSE VALIANTLAB